If your patient is 12+ years and has moderate-to-severe asthma characterized by an eosinophilic phenotype, DUPIXENT is available in 200 mgn and 300 mgo doses. The 200 mg treatment, given every 2 weeks, has an initial loading dose of 400 mg (2 x 200 mg pre-filled pens or syringes), and the 300 mg treatment, given every 2 weeks, has an initial loading dose of 600 mg (2 x 300 mg pre-filled pens or syringes).1
If your patient is 12+ years and has OCS-dependent asthma or comorbid moderate-to-severe atopic dermatitis or is an adult with comorbid chronic rhinosinusitis with nasal polyposis, the recommended dose is an initial loading dose of 600 mg (2 x 300 mg pre-filled pens or syringes) followed by every-2-week dosing of a 300 mg pre-filled pen or syringe.1
If your patient is aged 6-11 years with uncontrolled moderate-to-severe asthma for which DUPIXENT is indicated, the dosing is weight-based. For children weighing 15 kgp to less than 30 kg, the recommended dose is 300 mg given every 4 weeks via a pre-filled pen or syringe. For children weighing 30 kgq or more, the recommended dose is 200 mg given every 2 weeks via a pre-filled pen or syringe. For children aged 6-11 years with asthma and comorbid moderate-to-severe atopic dermatitis, follow the recommended dosage for atopic dermatitis, which includes an initial loading dose.1
n200 mg=1.14 mL solution.
o300 mg=2 mL solution.
p15 kg is equal to 33 lb.
q30 kg is equal to 66 lb.